Eye drops for VKC

Colin Kerr

Published: Friday, December 7, 2018

Santen UK Limited has launched Verkazia eye drops emulsion containing 0.1% (1mg/ml) ciclosporin for the treatment of severe vernal keratoconjunctivitis (VKC) in children from 4 years of age and adolescents. “We know how important this new treatment option is for children suffering from this serious and life-changing condition,” said Dr Atiya Kenworthy, Medical Affairs, Santen. The recommended dose will be one drop administered four times a day to each affected eye, 15 minutes after any other eye drops. http://www.santen.com/

Latest Articles

Thinking Beyond Optics: Diversity, Equity, and Inclusion (DEI) and Unconscious Bias in Ophthalmology

Beyond Sight: A Clearer Vision for Equity in Ophthalmology

Refractions of Bias: Seeing DEI Clearly in Ophthalmology

Happy Patients, Higher Volumes

Digitalisation reduces errors and saves time, making a surgeon’s life easier.

Addressing Postoperative Visual Complications

Managing aberrations after laser refractive surgery requires a multi-layered approach.

3D Printing Helps Transform Ukrainian Eye Care

The country’s ophthalmologists offer valuable experience in treating ocular trauma and prosthesis design.

Winning Essay Says ‘Collective Desire’ Must Drive DEI Implementation

Emerging Microbial Trends That Could Affect Your Practices

A triptych of challenges paints a concerning picture for ophthalmologists across the globe.

Improving Outcomes with Laser-Assisted Surgery

Femtosecond laser offers a multifunctional tool for improving the safety and efficacy of cataract and refractive lens exchange procedures.

Could the Corneal Transplant Pool Increase?

Modifying or discarding major contraindications for keratoplasty could mean more patients have their sight restored.